PD Dr. med. Athina Papadopoulou

Schoenholzer, K., Sellathurai, S., Villena, F. B., & Papadopoulou, A. (2024). Hemimacular Thinning Due to Lesions in the Lateral Geniculate Nucleus in 2 Patients With Neuroinflammatory Diseases [Journal-article]. Neurology Neuroimmunology & Neuroinflammation, 11(6). https://doi.org/10.1212/nxi.0000000000200297

Papadopoulou, Athina, Pfister, Armanda, Tsagkas, Charidimos, Gaetano, Laura, Sellathurai, Shaumiya, D’Souza, Marcus, Cerdá-Fuertes, Nuria, Gugleta, Konstantin, Descoteaux, Maxime, Chakravarty, Mallar M., Fuhr, Peter, Kappos, Ludwig, Granziera, Cristina, Magon, Stefano, Sprenger, Till, & Hardmeier, Martin. (2024). Visual evoked potentials in multiple sclerosis: P100 latency and visual pathway damage including the lateral geniculate nucleus [Journal-article]. Clinical Neurophysiology, 161, 122–132. https://doi.org/10.1016/j.clinph.2024.02.020

Zhu, Jie, Hassler, Caterina, Villena, Federico Burguet, Papadopoulou, Athina, Navarini, Alexander A., & Mueller, Simon M. (2024). Reverse underwear sign as an indicator of alloknesis [Journal-article]. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15320

Gloor, Monika, Andelova, Michaela, Gaetano, Laura, Papadopoulou, Athina, Burguet Villena, Federico, Sprenger, Till, Radue, Ernst-Wilhelm, Kappos, Ludwig, Bieri, Oliver, & Garcia, Meritxell. (2024). Longitudinal analysis of new multiple sclerosis lesions with magnetization transfer and diffusion tensor imaging. European Radiology, 34, 1680–1691. https://doi.org/10.1007/s00330-023-10173-6

Kulsvehagen, L., Woelfle, T., Ayroza Galvão Ribeiro Gomes, A. B., Lipps, P., Neziraj, T., Flammer, J., Leuzinger, K., Derfuss, T., Kuhle, J., Papadopoulou, A., & Pröbstel, A.-K. (2024). Case report: Concurrent MOG antibody-associated disease and latent infections in two patients. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1455355

Pakeerathan, T., Havla, J., Schwake, C., Salmen, A., Ringelstein, M., Aktas, O., Weise, M., Gernert, J.A., Kornek, B., Bsteh, G., Pröbstel, A.-K., Papadopoulou, A., Kulsvehagen, L., Ayroza Galvão Ribeiro Gomes, A.B., Cerdá-Fuertes, N., Oertel, F.C., Duchow, A.S., Paul, F., Stellmann, J.P., et al. (2024). Rapid differentiation of MOGAD and MS after a single optic neuritis. Journal of Neurology. https://doi.org/10.1007/s00415-024-12666-w

Papadopoulou, A., Pfister, A., Tsagkas, C., Gaetano, L., Sellathurai, S., D’Souza, M., Cerdá-Fuertes, N., Gugleta, K., Descoteaux, M., Chakravarty, M. M., Fuhr, P., Kappos, L., Granziera, C., Magon, S., Sprenger, T., & Hardmeier, M. (2024). Visual evoked potentials in multiple sclerosis: P100 latency and visual pathway damage including the lateral geniculate nucleus. Clinical Neurophysiology, 161, 122–132. https://doi.org/10.1016/j.clinph.2024.02.020

Vidal-Jordana, Angela, Rovira, Alex, Calderon, Willem, Arrambide, Georgina, Castilló, Joaquín, Moncho, Dulce, Rahnama, Kimia, Collorone, Sara, Toosy, Ahmed T., Ciccarelli, Olga, Papadopoulou, Athina, Cerdá-Fuertes, Nuria, Lieb, Johanna M., Ruggieri, Serena, Tortorella, Carla, Gasperini, Claudio, Bisecco, Alvino, Capuano, Rocco, Gallo, Antonio, et al. (2024). Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study. Neurology, 102. https://doi.org/10.1212/wnl.0000000000207805

Zhu, Jie, Hassler, Caterina, Villena, Federico Burguet, Papadopoulou, Athina, Navarini, Alexander A., & Mueller, Simon M. (2024). Reverse underwear sign as an indicator of alloknesis. JDDG - Journal of the German Society of Dermatology, 22, 574–575. https://doi.org/10.1111/ddg.15320

Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Lipps, Patrick, Cagol, Alessandro, Cerdá-Fuertes, Nuria, Neziraj, Tradite, Flammer, Julia, Lerner, Jasmine, Lecourt, Anne-Catherine, de Oliveira S. Siebenborn, Nina, Cortese, Rosa, Schaedelin, Sabine, Andreoli Schoeps, Vinicius, de Moura Brasil Matos, Aline, Trombini Mendes, Natalia, dos Reis Pereira, Clarissa, Ribeiro Monteiro, Mario Luiz, dos Apóstolos-Pereira, Samira Luisa, Schindler, Patrick, et al. (2023). Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients With Central Nervous System Demyelination [Journal-article]. JAMA Neurology, 80(9), 989. https://doi.org/10.1001/jamaneurol.2023.2523

Cagol A., Fuertes N.C., Stoessel M., Barakovic M., Schaedelin S., D’Souza M, Wurfel J., Brandt A.U., Kappos L., Sprenger T, Naegelin Y, Kuhle J, Granziera C, & Papadopoulou A. (2023). Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis. Journal of Neurology, 270(4), 2139–2148. https://doi.org/10.1007/s00415-022-11535-8

Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Lipps, Patrick, Cagol, Alessandro, Cerdá-Fuertes, Nuria, Neziraj, Tradite, Flammer, Julia, Lerner, Jasmine, Lecourt, Anne-Catherine, De Oliveira S. Siebenborn, Nina, Cortese, Rosa, Schaedelin, Sabine, Andreoli Schoeps, Vinicius, De Moura Brasil Matos, Aline, Trombini Mendes, Natalia, Dos Reis Pereira, Clarissa, Ribeiro Monteiro, Mario Luiz, Dos Apóstolos-Pereira, Samira Luisa, Schindler, Patrick, et al. (2023). Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients with Central Nervous System Demyelination. JAMA Neurology, 80, 989–995. https://doi.org/10.1001/jamaneurol.2023.2523

Cerdá-Fuertes, Nuria, Nagy, Sara, Schaedelin, Sabine, Sinnecker, Tim, Ruberte, Esther, Papadopoulou, Athina, Würfel, Jens, Kuhle, Jens, Yaldizli, Özgür, Kappos, Ludwig, Derfuss, Tobias, & Décard, Bernhard F. (2023). Evaluation of frequency, severity, and independent risk factors for recurrence of disease activity after fingolimod discontinuation in a large real-world cohort of patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders, 16. https://doi.org/10.1177/17562864221150312

Cerdá-Fuertes, Nuria, Stoessel, Marc, Mickeliunas, Gintaras, Pless, Silvan, Cagol, Alessandro, Barakovic, Muhamed, Maceski, Aleksandra Maleska, Álvarez González, Cesar, D’ Souza, Marcus, Schaedlin, Sabine, Benkert, Pascal, Calabrese, Pasquale, Gugleta, Konstantin, Derfuss, Tobias, Sprenger, Till, Granziera, Cristina, Naegelin, Yvonne, Kappos, Ludwig, Kappos, Ludwig, et al. (2023). Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis. Multiple Sclerosis Journal, 29, 1540–1550. https://doi.org/10.1177/13524585231198760

Lipps, Patrick, Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Mutke, Matthias Anthony, Kuhle, Jens, Papadopoulou, Athina, & Pröbstel, Anne-Katrin. (2023). Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurology, 80, 1377–1379. https://doi.org/10.1001/jamaneurol.2023.3956

Overeem, Lucas Hendrik, Raffaelli, Bianca, Fleischmann, Robert, Süße, Marie, Vogelgesang, Antje, Maceski, Aleksandra Maleska, Papadopoulou, Athina, Ruprecht, Klemens, Su, Wendy, Koch, Mirja, Siebert, Anke, Arkuszewski, Michal, Tenenbaum, Nadia, Kuhle, Jens, & Reuter, Uwe. (2023). Serum tau protein elevation in migraine: a cross-sectional case–control study. Journal of Headache and Pain, 24. https://doi.org/10.1186/s10194-023-01663-5

Friedli, C., Salmen, A., Hoepner, R., Achtnichts, L., Bigi, S., Derfuss, T., Gobbi, C., Kamber, N., Kamm, C. P., Kuhle, J., Lalive, P., Müller, S., Papadopoulou, A., Pot, C., Zecca, C., & Chan, A. (2022). Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022 [Journal-article]. Clinical and Translational Neuroscience, 7(1), 2. https://doi.org/10.3390/ctn7010002

Kenney R, Liu M, Hasanaj L, Joseph B, Al-Hassan AA, Balk L, Behbehani R, Brandt AU, Calabresi PA, Frohman EM, Frohman T, Havla J, Hemmer B, Jiang H, Knier B, Korn T, Leocani L, Martínez-Lapiscina EH, Papadopoulou A, et al. (2022). Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort. Journal of Neuro-Ophthalmology : The Official Journal of the North American Neuro-Ophthalmology Society, 42(4), 442–453. https://doi.org/10.1097/wno.0000000000001717

Kenney RC, Liu M, Hasanaj L, Joseph B, Abu Al-Hassan A, Balk LJ, Behbehani R, Brandt A, Calabresi PA, Frohman E, Frohman TC, Havla J, Hemmer B, Jiang H, Knier B, Korn T, Leocani L, Martinez-Lapiscina EH, Papadopoulou A, et al. (2022). The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis. Neurology, 99(11), e1100–e1112. https://doi.org/10.1212/wnl.0000000000200883

Stamatellos VP, Rigas A, Stamoula E, Lallas A, Papadopoulou A, & Papazisis G. (2022). S1P receptor modulators in Multiple Sclerosis: Detecting a potential skin cancer safety signal. Multiple Sclerosis and Related Disorders, 59, 103681. https://doi.org/10.1016/j.msard.2022.103681

Tsagkas C, Geiter E, Gaetano L, Naegelin Y, Amann M, Parmar K, Papadopoulou A, Wuerfel J, Kappos L, Sprenger T, Granziera C, Mallar Chakravarty M, & Magon S. (2022). Longitudinal changes of deep gray matter shape in multiple sclerosis. NeuroImage. Clinical, 35, 103137. https://doi.org/10.1016/j.nicl.2022.103137

Wolleb, Julia, Sandkühler, Robin, Bieder, Florentin, Barakovic, Muhamed, Hadjikhani, Nouchine, Papadopoulou, Athina, Yaldizli, Özgür, Kuhle, Jens, Granziera, Cristina, & Cattin, Philippe C. (2022). Learn to Ignore: Domain Adaptation for Multi-site MRI Analysis. Medical Image Computing and Computer Assisted Intervention – MICCAI 2022, 13437 LNCS, 725–735. https://doi.org/10.1007/978-3-031-16449-1_69

Anastasiou A, Rusche N, Blackham KA, & Papadopoulou A. (2022). MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis.

Anastasiou A, Rusche N, Blackham KA, & Papadopoulou A. (2022). MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis: Vol. 4 (3) (p. 226).

Anastasiou A, Rusche N, Blackham KA, & Papadopoulou A. (2022). MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis: Vol. 4 (3) (NA; p. 226).

Anastasiou A, Rusche N, Blackham KA, & Papadopoulou A. (2022). MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis: Vol. 4 (3) (No. 4; p. 226).

Anastasiou A, Rusche N, Blackham KA, & Papadopoulou A. (2022). MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis: Vol. 4 (3) (No. 4; p. 226).

Anastasiou A, Rusche N, Blackham KA, & Papadopoulou A. (2022). MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis: Vol. 4 (3) (No. 4; p. 226).

Anastasiou A, Rusche N, Blackham KA, & Papadopoulou A. (2022). MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis: Vol. 4 (3) (No. 4; p. 226).

Anastasiou A, Rusche N, Blackham KA, & Papadopoulou A. (2022). MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis: Vol. 4 (3) (No. 4; 2022 ed., p. 226).

Tsagkas C, Naegelin Y, Amann M, Papadopoulou A, Barro C., Chakravarty M.M., Gaetano L., Wuerfel J., Kappos L., Kuhle J, Granziera C., Sprenger T, Magon S., & Parmar K. (2021). Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort. European Journal of Neurology, 28(12), 4153–4166. https://doi.org/10.1111/ene.15098

Lin TY, Vitkova V, Asseyer S, Martorell Serra I, Motamedi S, Chien C, Ditzhaus M, Papadopoulou A, Benkert P, Kuhle J, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU, & Zimmermann HG. (2021). Increased Serum Neurofilament Light and Thin Ganglion Cell-Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis. Neurology(R) Neuroimmunology & Neuroinflammation, 8(5). https://doi.org/10.1212/nxi.0000000000001051

D’Souza M, Papadopoulou A, Girardey C, & Kappos L. (2021). Standardization and digitization of clinical data in multiple sclerosis. Nature Reviews. Neurology, 17(2), 119–125. https://doi.org/10.1038/s41582-020-00448-7

Papadopoulou A, Oertel F.C., Chien C., Kuchling J., Zimmermann H.G., Siebert N., Motamedi S., Souza M, Asseyer S., Bellmann-Strobl J., Ruprecht K., Chakravarty M.M., Scheel M., Magon S., Wuerfel J., Paul F, & Brandt A.U. (2021). Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study. NeuroImage. Clinical, 30, 102608. https://doi.org/10.1016/j.nicl.2021.102608

Tsagkas, Charidimos, Parmar, Katrin, Pezold, Simon, Barro, Christian, Chakravarty, Mallar M., Gaetano, Laura, Naegelin, Yvonne, Amann, Michael, Papadopoulou, Athina, Wuerfel, Jens, Kappos, Ludwig, Kuhle, Jens, Sprenger, Till, Granziera, Cristina, & Magon, Stefano. (2021). Classification of multiple sclerosis based on patterns of CNS regional atrophy covariance. Human Brain Mapping, 42(8), 2399–2415. https://doi.org/10.1002/hbm.25375

Magon S., Pfister A., Laura G., Luthi M., Papadopoulou A., Kappos L., & Sprenger T. (2020). Short timescale modulation of cortical and cerebellar activity in the early phase of motor sequence learning: an fMRI study. Brain Imaging and Behavior, 14(6), 2159–2175. https://doi.org/10.1007/s11682-019-00167-8

Asseyer S, Kuchling J, Gaetano L, Komnenić D, Siebert N, Chien C, Scheel M, Oertel FC, Ruprecht K, Bellmann-Strobl J, Finke C, Chakravarty MM, Magon S, Wuerfel J, Paul F, Papadopoulou A, & Brandt AU. (2020). Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders, 46, 102579. https://doi.org/10.1016/j.msard.2020.102579

Juenger V, Cooper G, Chien C, Chikermane M, Oertel FC, Zimmermann H, Ruprecht K, Jarius S, Siebert N, Kuchling J, Papadopoulou A, Asseyer S, Bellmann-Strobl J, Paul F, Brandt AU, & Scheel M. (2020). Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders. European Radiology, 30(9), 5048–5058. https://doi.org/10.1007/s00330-020-06859-w

D’Souza M, Heikkilä A, Lorscheider J, Haller V, Kravalis K, Gysin S, Fuertes NAC, Fricker E, Lam E, Higgins P, Tomic D, Papadopoulou A, & Kappos L. (2020). Electronic Neurostatus-EDSS increases the quality of expanded disability status scale assessments: Experience from two phase 3 clinical trials. Multiple Sclerosis Journal, 26(8), 993–996. https://doi.org/10.1177/1352458519845108

D’Souza M, Papadopoulou A, Levy M, Jacob A, Yeaman MR, Kümpfel T, Marignier R, Paul F, & Brandt AU. (2020). Diagnostic procedures in suspected attacks in patients with neuromyelitis optica spectrum disorders: Results of an international survey. Multiple Sclerosis and Related Disorders, 41, 102027. https://doi.org/10.1016/j.msard.2020.102027

Zuber P, Tsagkas C, Papadopoulou A, Gaetano L, Huerbin M, Geiter E, Altermatt A, Parmar K, Ettlin T, Schuster-Amft C, Suica Z, Alrasheed H, Wuerfel J, Kesselring J, Kappos L, Sprenger T, & Magon S. (2020). Efficacy of inpatient personalized multidisciplinary rehabilitation in multiple sclerosis: behavioural and functional imaging results. Journal of Neurology, 267(6), 1744–1753. https://doi.org/10.1007/s00415-020-09768-6

Magon S, Tsagkas C, Gaetano L, Patel R, Naegelin Y, Amann M, Parmar K, Papadopoulou A, Wuerfel J, Stippich C, Kappos L, Chakravarty MM, & Sprenger T. (2020). Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis. Journal of Neurology, 267(5), 1536–1546. https://doi.org/10.1007/s00415-020-09740-4

Derfuss T, Mehling M, Papadopoulou A, Bar-Or A, Cohen JA, & Kappos L. (2020). Advances in oral immunomodulating therapies in relapsing multiple sclerosis. The Lancet. Neurology, 19(4), 336–347. https://doi.org/10.1016/s1474-4422(19)30391-6

Kronlage C, Papadopoulou A, & De Marchis GM. (2020). Isolated oculomotor palsy due to acute ischemic midbrain stroke. Acta Neurologica Belgica, 120(2), 479–481. https://doi.org/10.1007/s13760-018-0918-8

Gkaniatsou T, Papadopoulou A, Paul F, Brandt AU, & Oertel FC. (2020). Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders. (Patent No. 1). 120(1), Article 1. https://doi.org/10.1007/s13760-019-01176-6

Charidimos, Tsagkas, M. Mallar, Chakravarty, Laura, Gaetano, Yvonne, Naegelin, Michael, Amann, Katrin, Parmar, Athina, Papadopoulou, Jens, Wuerfel, Ludwig, Kappos, Till, Sprenger, & Stefano, Magon. (2020). Longitudinal patterns of cortical thinning in multiple sclerosis. Human Brain Mapping, 41(8), 2198–2215. https://doi.org/10.1002/hbm.24940

Zuber, Priska, Tsagkas, Charidimos, Papadopoulou, Athina, Gaetano, Laura, Huerbin, Manuel, Geiter, Emanuel, Altermatt, Anna, Parmar, Katrin, Ettlin, Thierry, Schuster‐Amft, Corina, Suica, Zorica, Alrasheed, Hala, Wuerfel, Jens, Kesselring, Jürg, Kappos, Ludwig, Sprenger, Till, & Magon, Stefano. (2020). Efficacy of inpatient personalized multidisciplinary rehabilitation in multiple sclerosis: behavioural and functional imaging results. Journal of Neurology, 1–10. https://doi.org/10.1007/s00415-020-09768-6

Papadopoulou A, Gaetano L, Pfister A, Altermatt A, Tsagkas C, Morency F, Brandt AU, Hardmeier M, Chakravarty MM, Descoteaux M, Kappos L, Sprenger T, & Magon S. (2019). Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway. Neurology, 92(19), E2240–E2249. https://doi.org/10.1212/wnl.0000000000007450

Nolan-Kenney RC, Liu M, Akhand O, Calabresi PA, Paul F, Petzold A, Balk L, Brandt AU, Martínez-Lapiscina EH, Saidha S, Villoslada P, Al-Hassan AA, Behbehani R, Frohman EM, Frohman T, Havla J, Hemmer B, Jiang H, Knier B, et al. (2019). Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study. Annals of Neurology, 85(5), 618–629. https://doi.org/10.1002/ana.25462

Papadopoulou, Athina, Oertel, Frederike Cosima, Gaetano, Laura, Kuchling, Joseph, Zimmermann, Hanna, Chien, Claudia, Siebert, Nadja, Asseyer, Susanna, Bellmann-Strobl, Judith, Klemens, Ruprecht, Chakravarty, M. Mallar, Scheel, Michael, Magon, Stefano, Würfel, Jens, Paul, Friedemann, & Brandt, Alexander Ulrich. (2019). Attack-related damage of Thalamic Nuclei in Neuromyelitis Optica Spectrum Disorders. Journal of neurology, neurosurgery and psychiatry. https://doi.org/10.1136/jnnp-2018-320249

Papadopoulou A, Oertel FC, Zimmermann H, Zeitz O, Brandt AU, & Paul F. (2018). [Optical Coherence Tomography in Disorders of the Central Nervous System]. Klinische Monatsblatter fur Augenheilkunde, 235(11), 1242–1258. https://doi.org/10.1055/a-0715-7961

Magon S, Sprenger T, Otti A, Papadopoulou A, Gündel H, & Noll-Hussong M. (2018). Cortical Thickness Alterations in Chronic Pain Disorder: An Exploratory MRI Study. Psychosomatic medicine, 80(7), 592–598. https://doi.org/10.1097/psy.0000000000000605

Papadopoulou A, Kronlage C, Kampmann M, & Budweg J. (2018). Unilateral leg oedema due to spontaneous Achilles tendon rupture. (No. 6; Vol. 2018, p. omy022). https://doi.org/10.1093/omcr/omy022

Seifert CL, Schönbach EM, Zimmer C, Förschler A, Tölle TR, Feurer R, Gempt J, Papadopoulou A, Magon S, Sprenger T, & Poppert H. (2018). Association of clinical headache features with stroke location: An MRI voxel-based symptom lesion mapping study. (Patent No. 2). 38(2), Article 2. https://doi.org/10.1177/0333102416686342

Hanssen, H., Minghetti, A., Magon, S., Rossmeissl, A., Rasenack, M., Papadopoulou, A., Klenk, C., Faude, O., Zahner, L., Sprenger, T., & Donath, L. (2018). Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: A randomized controlled trial. Scandinavian Journal of Medicine & Science in Sports, 28(3), 1103–1112. https://doi.org/10.1111/sms.13023

Papadopoulou A, Derfuss T, & Sprenger T. (2017). Daclizumab for the treatment of multiple sclerosis. Neurodegenerative disease management, 7(5), 279–297. https://doi.org/10.2217/nmt-2017-0023

Petzold, A., Balcer, L., Calabresi, P. A., Costello, F., Frohman, T., Frohman, E., Martínez-Lapiscina, E. H., Green, A., Kardon, R., Outteryck, O., Paul, F., Schippling, S., Vermersch, P., Villoslada, P., Balk, L., Aktas, O., Albrecht, P., Ashworth, J., Asgari, N., et al. (2017). Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. The Lancet Neurology, 16(10), 797–812. https://doi.org/10.1016/s1474-4422(17)30278-8

D’Souza M, Yaldizli Ö, John R, Vogt DR, Papadopoulou A, Lucassen E, Menegola M, Andelova M, Dahlke F, Schnyder F, & Kappos L. (2017). Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study. Multiple Sclerosis (Houndmills, Basingstoke, England), 23(4), 597–603. https://doi.org/10.1177/1352458516657439

Andermatt, Simon, Papadopoulou, Athina, Radue, Ernst-Wilhelm, Sprenger, Till, & Cattin, Philippe C. (2017). Tracking the Evolution of Cerebral Gadolinium-enhancing Lesions to Persistent T1 Black Holes in Multiple Sclerosis: Validation of a Semiautomated Pipeline. Journal of Neuroimaging, 27(5), 469–475. https://doi.org/10.1111/jon.12439

Hanssen, Henner, Minghetti, Alice, Magon, Stefano, Rossmeissl, Anja, Papadopoulou, Athina, Klenk, Christopher, Schmidt-Trucksäss, Arno, Faude, Oliver, Zahner, Lukas, Sprenger, Till, & Donath, Lars. (2017). Superior Effects of High-Intensity Interval Training vs. Moderate Continuous Training on Arterial Stiffness in Episodic Migraine: A Randomized Controlled Trial. Frontiers in Physiology, 8, 1086. https://doi.org/10.3389/fphys.2017.01086

Papadopoulou A, Ahlhelm FJ, Lyrer P, & Kuhle J. (2015). Decision for intravenous thrombolysis in a young patient with acute vertical gaze palsy. (Patent No. 3). 115(3), Article 3. https://doi.org/10.1007/s13760-014-0356-1

Amann M, Papadopoulou A, Andelova M, Magon S, Mueller-Lenke N, Naegelin Y, Stippich C, Radue EW, Bieri O, Kappos L, & Sprenger T. (2015). Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis. Journal of Neurology, 262(8), 1909–1917. https://doi.org/10.1007/s00415-015-7793-5

Papadopoulou A, Kappos L, & Sprenger T. (2015). Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis. Expert opinion on drug safety, 14(5), 749–759. https://doi.org/10.1517/14740338.2015.1014795

Papadopoulou A, Naegelin Y, Weier K, Amann M, Hirsch J, von Felten S, Yaldizli O, Sprenger T, Radue EW, Kappos L, & Gass A. (2014). MRI characteristics of periaqueductal lesions in multiple sclerosis. Multiple Sclerosis and Related Disorders, 3(4), 542–551. https://doi.org/10.1016/j.msard.2014.01.001

Papadopoulou A, Ahlhelm FJ, & Sprenger T. (2014). Intrathecal gadolinium for magnetic resonance myelography in spontaneous intracranial hypotension: valuable but may be risky--reply. (Patent No. 6). 71(6), Article 6. https://doi.org/10.1001/jamaneurol.2014.577

Papadopoulou, A., Menegola, M., Kuhle, J., Ramagopalan, S. V., D’Souza, M., Sprenger, T., Radue, E. W., Kappos, L., & Yaldizli, O. (2014). Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 20(3), 322–330. https://doi.org/10.1177/1352458513495583

Yaldizli, O., Penner, I. K., Frontzek, K., Naegelin, Y., Amann, M., Papadopoulou, A., Sprenger, T., Kuhle, J., Calabrese, P., Radu, E. W., Kappos, L., & Gass, A. (2014). The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients. Multiple Sclerosis Journal, 20(3), 356–364. https://doi.org/10.1177/1352458513496880

Papadopoulou A, Ahlhelm FJ, Ulmer S, Kappos L, & Sprenger T. (2013). Detection of cerebrospinal fluid leaks by intrathecal contrast-enhanced magnetic resonance myelography. JAMA Neurology, 70(12), 1576–1577. https://doi.org/10.1001/jamaneurol.2013.744

Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K., Kuster P, Stoecklin M, Gass A, Sprenger T., Radue E.W., Kappos L, & Penner IK. (2013). Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis. Multiple Sclerosis Journal, 19(10), 1290–1296. https://doi.org/10.1177/1352458513475490

Papadopoulou A, Kappos L, & Sprenger T. (2012). Teriflunomide for oral therapy in multiple sclerosis. Expert Review of Clinical Pharmacology, 5(6), 617–628. https://doi.org/10.1586/ecp.12.56

Papadopoulou A, von Felten S, Traud S, Rahman A, Quan J, King R, Garren H, Steinman L, Cutter G, Kappos L, & Radue EW. (2012). Evolution of MS lesions to black holes under DNA vaccine treatment. Journal of neurology, 259(7), 1375–1382. https://doi.org/10.1007/s00415-011-6361-x

Yaldizli Ö, Glassl S, Sturm D, Papadopoulou A, Gass A, Tettenborn B, & Putzki N. (2011). Fatigue and progression of corpus callosum atrophy in multiple sclerosis. Journal of neurology, 258(12), 2199–2205. https://doi.org/10.1007/s00415-011-6091-0

Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW, & SENTINEL Investigators. (2010). Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis. Journal of the neurological sciences, 292(1-2), 28–35. https://doi.org/10.1016/j.jns.2010.02.012

Papadopoulou, Athina, D’Souza, Marcus, Kappos, Ludwig, & Yaldizli, Ozgür. (2010). Dimethyl fumarate for multiple sclerosis. Expert Opinion on Investigational Drugs, 19(12), 1603–1612. https://doi.org/10.1517/13543784.2010.534778